|
|
Next Article 
Graft-versus-host disease: new directions for a persistent problem
GB Vogelsang and AD Hess
Johns Hopkins University School of Medicine, Bone Marrow Transplant Unit,
Baltimore, MD 21287-8985.
Graft-versus-host disease (GVHD) continues to be a major complication after
allogeneic bone marrow transplantation, especially with the increasing use
of unrelated and mismatched donors. Recently there has been renewed
scientific interest in GVHD because of the increasing appreciation of the
complexity of the immune responses seen in GVHD. Two basic aspects of the
immune response in GVHD, the immunologic target and the effector
mechanisms, are now more completely understood. First, the target of the
immune response in GVHD has long been felt to be histocompatibility
antigens possessed by the host, but not the donor. Recently, recognition of
self antigens in GVHD has been documented, showing that GVHD is more
complex than simple alloreactivity. Second, the effector mechanism in GVHD
was initially felt to be direct cytotoxicity by alloreactive T cells. It is
now recognized that cytokines play a central role in mediating many of the
clinical and experimental manifestations of GVHD. The development in these
two areas will be reviewed and the implications for clinical
transplantation discussed.
Volume 84,
Issue 7,
pp. 2061-2067,
10/01/1994
Copyright © 1994 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. Miura, C. J. Thoburn, E. C. Bright, M. L. Phelps, T. Shin, E. C. Matsui, W. H. Matsui, S. Arai, E. J. Fuchs, G. B. Vogelsang, et al.
Association of Foxp3 regulatory gene expression with graft-versus-host disease
Blood,
October 1, 2004;
104(7):
2187 - 2193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Yamamoto, T. Tsuji, J. Matsuzaki, Y. Zhange, K. Chamoto, A. Kosaka, Y. Togashi, K. Sekikawa, K.-i. Sawada, T. Takeshima, et al.
Unexpected role of TNF-{alpha} in graft versus host reaction (GVHR): donor-derived TNF-{alpha} suppresses GVHR via inhibition of IFN-{gamma}-dependent donor type-1 immunity
Int. Immunol.,
June 1, 2004;
16(6):
811 - 817.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Catalina, L. Milewich, V. Kumar, and M. Bennett
Dietary Dehydroepiandrosterone Inhibits Bone Marrow and Leukemia Cell Transplants: Role of Food Restriction
Experimental Biology and Medicine,
December 1, 2003;
228(11):
1303 - 1320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Socie, N. Salooja, A. Cohen, A. Rovelli, E. Carreras, A. Locasciulli, E. Korthof, J. Weis, V. Levy, and A. Tichelli
Nonmalignant late effects after allogeneic stem cell transplantation
Blood,
May 1, 2003;
101(9):
3373 - 3385.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Miura, C. J. Thoburn, E. C. Bright, W. Chen, S. Nakao, and A. D. Hess
Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD
Blood,
September 18, 2002;
100(7):
2650 - 2658.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Miura, C. J. Thoburn, E. C. Bright, M. Sommer, S. Lefell, M. Ueda, S. Nakao, and A. D. Hess
Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD
Blood,
August 1, 2001;
98(3):
868 - 876.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.L.U. del Rosario, J. R. Zucali, and K.J. Kao
Prevention of Graft-Versus-Host Disease by Induction of Immune Tolerance With Ultraviolet B-Irradiated Leukocytes in H-2 Disparate Bone Marrow Donor
Blood,
May 15, 1999;
93(10):
3558 - 3564.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M WILLIAMSON
Transfusion associated graft versus host disease and its prevention
Heart,
September 1, 1998;
80(3):
211 - 212.
[Full Text]
|
|
|
|
|
|
|
J. G. Clark, D. K. Madtes, R. C. Hackman, W. Chen, M. A. Cheever, and P. J. Martin
Lung Injury Induced by Alloreactive Th1 Cells Is Characterized by Host-Derived Mononuclear Cell Inflammation and Activation of Alveolar Macrophages
J. Immunol.,
August 15, 1998;
161(4):
1913 - 1920.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Hattori, T. Hirano, H. Miyajima, N. Yamakawa, M. Tateno, K. Oshimi, N. Kayagaki, H. Yagita, and K. Okumura
Differential Effects of Anti-Fas Ligand and Anti-Tumor Necrosis Factor alpha Antibodies on Acute Graft-Versus-Host Disease Pathologies
Blood,
June 1, 1998;
91(11):
4051 - 4055.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Bonini, G. Ferrari, S. Verzeletti, P. Servida, E. Zappone, L. Ruggieri, M. Ponzoni, S. Rossini, F. Mavilio, C. Traversari, et al.
HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
Science,
June 13, 1997;
276(5319):
1719 - 1724.
[Abstract]
[Full Text]
|
|
|
|
|
